Investments soleno stock soars 32 on 2 9 billion neurocrine buyout investments us similispharma@gmail.comApril 6, 20260 The world of pharmaceuticals has just witnessed a monumental shift with Soleno Therapeutics’ stock soaring an unprecedented 32% following a…
